相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
Wenxi Zhou et al.
BIOMATERIALS (2021)
Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer
Yu Hang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy
Ying Xie et al.
ACS NANO (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Heng Zhu et al.
MOLECULAR CANCER (2020)
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Cheng Qin et al.
MOLECULAR CANCER (2020)
New Mechanism of Gemcitabine and Its Phosphates: DNA Polymerization Disruption via 3′-5′ Exonuclease Inhibition
Shuzhang Yang et al.
BIOCHEMISTRY (2020)
The Effect of Gemcitabine on Cell Cycle Arrest and microRNA Signatures in Pancreatic Cancer Cells
Daisuke Namima et al.
IN VIVO (2020)
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
Ivy X. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
Kamalika Samanta et al.
PHARMACEUTICS (2019)
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer
Hadas Gibori et al.
NATURE COMMUNICATIONS (2018)
Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists
Pengkai Wu et al.
MACROMOLECULAR BIOSCIENCE (2018)
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
Richard L. Sleightholm et al.
PHARMACOLOGY & THERAPEUTICS (2017)
PLK1, A Potential Target for Cancer Therapy
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2017)
Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery
Ning Gao et al.
THERANOSTICS (2017)
Current Standards of Chemotherapy for Pancreatic Cancer
May Tun Saung et al.
CLINICAL THERAPEUTICS (2017)
Gemcitabine induces cell senescence in human pancreatic cancer cell lines
Yao Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis
Yan Wang et al.
BIOMATERIALS (2016)
Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists
Mamoru Morimoto et al.
BMC CANCER (2016)
Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer
Jie Li et al.
CELL CYCLE (2016)
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Yoav Binenbaum et al.
DRUG RESISTANCE UPDATES (2015)
Promising molecular mechanisms responsible for gemcitabine resistance in cancer
Yanfei Jia et al.
GENES & DISEASES (2015)
Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors
Yusuke Oe et al.
BIOMATERIALS (2014)
Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor
Jing Li et al.
BIOMATERIALS (2014)
CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis
Yanan Sun et al.
TUMOR BIOLOGY (2014)
Dual-Function CXCR4 Antagonist Polyplexes To Deliver Gene Therapy and Inhibit Cancer Cell Invasion
Jing Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
S. Singh et al.
BRITISH JOURNAL OF CANCER (2010)
Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice
N. Mirahmadi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Klaus Strebhardt
NATURE REVIEWS DRUG DISCOVERY (2010)
Synthesis and gene transfection efficacies of PEI-cholesterol-based lipopolymers
Avinash Bajaj et al.
BIOCONJUGATE CHEMISTRY (2008)
CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer
D Saur et al.
GASTROENTEROLOGY (2005)
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
XQ Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
